---
id: cardiotoxicity
title: Cardiotoxicity
description: Endpoint page defining cardiotoxicity and summarizing relevant evidence types.
slug: /endpoints/cardiotoxicity
sidebar_label: Cardiotoxicity
page_type: endpoint
entity_class: endpoint
status: draft
last_reviewed: 2026-08-25
---

# Overview

Cardiotoxicity refers to the adverse effects on the heart caused by exposure to various substances, including drugs, environmental chemicals, and natural compounds. These effects can manifest as structural damage, functional impairment, or disruption of cardiac processes, leading to conditions such as arrhythmias, cardiomyopathy, or heart failure. The assessment of cardiotoxicity is critical in both clinical and regulatory settings to ensure the safety of therapeutic agents and environmental exposures.

# Scope and Notes

This page focuses on the definition, mechanisms, and assessment of cardiotoxicity, particularly in the context of computational toxicology. It covers the biological pathways involved, computational methods for prediction, and evidence types used to evaluate cardiotoxic potential. The discussion includes both drug-induced cardiotoxicity and cardiotoxicity arising from environmental exposures.

# Key Claims or Definitions

## Definition of Cardiotoxicity

**Claim ID:** clm-cardiotoxicity-001

**Statement:** Cardiotoxicity is the adverse effect on the heart caused by exposure to xenobiotics, including drugs and environmental chemicals, leading to structural or functional impairment.

**Subject:** Cardiotoxicity
**Predicate:** is_defined_as
**Object:** Adverse effect on the heart due to xenobiotic exposure

**Qualifiers:**
- **Context:** Toxicology
- **System:** Cardiovascular

**Citations:**
- cit-001

**Verification Status:** Supported
**Confidence:** High

---

## Mechanisms of Cardiotoxicity

**Claim ID:** clm-cardiotoxicity-002

**Statement:** Cardiotoxicity can arise from multiple mechanisms, including oxidative stress, mitochondrial dysfunction, ion channel dysfunction, and epigenetic repression.

**Subject:** Cardiotoxicity
**Predicate:** arises_from
**Object:** Multiple mechanisms (oxidative stress, mitochondrial dysfunction, ion channel dysfunction, epigenetic repression)

**Qualifiers:**
- **Context:** Mechanistic toxicology
- **System:** Cardiovascular

**Citations:**
- cit-002
- cit-003

**Verification Status:** Supported
**Confidence:** High

---

## Computational Assessment of Cardiotoxicity

**Claim ID:** clm-cardiotoxicity-003

**Statement:** Computational toxicology methods, such as Quantitative Structure-Activity Relationships (QSARs) and Quantitative Knowledge-Activity Relationships (QKARs), are used to predict cardiotoxic potential based on chemical structure and biological knowledge.

**Subject:** Computational toxicology
**Predicate:** uses_methods
**Object:** QSARs and QKARs for cardiotoxicity prediction

**Qualifiers:**
- **Context:** Predictive toxicology
- **System:** In silico

**Citations:**
- cit-004

**Verification Status:** Supported
**Confidence:** High

---

# Evidence or Details

## Biological Mechanisms

Cardiotoxicity can be induced through various biological mechanisms:

1. **Oxidative Stress:** Exposure to certain chemicals or drugs can lead to the generation of reactive oxygen species (ROS), causing oxidative damage to cardiac cells. This mechanism is particularly relevant in cases such as doxorubicin-induced cardiotoxicity, where oxidative stress plays a central role in cardiac dysfunction.

2. **Mitochondrial Dysfunction:** Disruption of mitochondrial function can impair energy production in cardiac cells, leading to cellular damage and dysfunction. This is often observed in cases involving environmental contaminants or certain therapeutic agents.

3. **Ion Channel Dysfunction:** Alterations in ion channel activity can lead to arrhythmias and other cardiac abnormalities. For example, inhibition of the hERG channel can result in prolonged QT intervals and increased risk of arrhythmias.

4. **Epigenetic Repression:** Some compounds induce cardiotoxicity through epigenetic mechanisms, such as histone deacetylase (HDAC) activation, leading to changes in gene expression and cellular function.

## Computational Methods

Computational toxicology employs various methods to predict and assess cardiotoxic potential:

1. **QSAR Models:** These models predict cardiotoxic effects based on the chemical structure of compounds. They rely on statistical relationships between chemical descriptors and observed toxicity data.

2. **QKAR Models:** These models integrate domain-specific knowledge with chemical structure data to enhance the prediction of cardiotoxic effects. They leverage broader biological and chemical knowledge to improve accuracy.

3. **Network Toxicology:** This approach uses network-based methods to identify potential targets and pathways involved in cardiotoxicity. It integrates data from multiple sources to provide a comprehensive view of the mechanisms underlying cardiotoxic effects.

4. **Molecular Docking:** This technique predicts the binding affinity between chemicals and cardiac-related proteins, providing insights into potential molecular interactions and mechanisms of action.

## Evidence Types

The evaluation of cardiotoxic potential relies on various types of evidence:

1. **In Vitro Assays:** These assays measure the effects of chemicals on cardiac cells or tissues in a controlled laboratory setting. Examples include assays for oxidative stress, mitochondrial function, and ion channel activity.

2. **In Vivo Studies:** Animal studies provide insights into the systemic effects of chemicals on the cardiovascular system. These studies can assess functional and structural changes in the heart following exposure.

3. **Clinical Data:** Observational and interventional studies in humans provide critical evidence for the cardiotoxic potential of drugs and environmental exposures. Clinical data include case reports, cohort studies, and randomized controlled trials.

4. **Computational Predictions:** In silico methods predict cardiotoxic potential based on chemical structure, biological pathways, and existing data. These methods are increasingly used to prioritize compounds for further testing and assessment.

# Related Pages

- [Hepatotoxicity](../hepatotoxicity.md)
- [Nephrotoxicity](../nephrotoxicity.md)
- [ToxCast Dataset](../../07-datasets/toxcast.md)
- [QSAR Prediction Workflow](../../11-workflows/qsar-prediction-workflow.md)

# Open Questions or Review Notes

1. **Mechanistic Gaps:** Further research is needed to fully elucidate the mechanisms underlying cardiotoxicity, particularly for emerging environmental contaminants and novel therapeutic agents.

2. **Predictive Accuracy:** While computational methods have shown promise in predicting cardiotoxic potential, improvements in accuracy and reliability are still needed to ensure their widespread adoption in regulatory settings.

3. **Integration of Evidence:** There is a need for better integration of in vitro, in vivo, and computational evidence to provide a comprehensive assessment of cardiotoxic risk.

# References

```yaml
citation_id: cit-001
title: "Oxidative DNA Damage as an Integrative Marker of Redox Dysfunction Associated with Doxorubicin-Induced Cardiotoxicity in Pediatric Leukemia"
authors:
  - Jesús Alonso Gándara-Mireles
  - Elio Aarón Reyes Espinoza
  - Verónica Loera-Castañeda
  - Lourdes Patricia Córdova Hurtado
  - Antonio Emilio González Font
  - Julio Cesar Grijalva Ávila
  - Ignacio Villanueva Fierro
  - Ismael Lares-Asseff
  - Cynthia Mora Muñoz
  - Gabriela Velasco Villa
  - Hugo Payán Gándara
  - Leslie Patrón-Romero
  - Horacio Almanza-Reyes
year: 2026
container: "Current Issues in Molecular Biology"
doi: 10.3390/cimb48060577
url: https://doi.org/10.3390/cimb48060577
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: null
notes: Supports the definition and mechanisms of cardiotoxicity, particularly oxidative stress.

---
citation_id: cit-002
title: "Emerging Role of Statin Therapy in Preventing Anthracycline-Induced Cardiotoxicity"
authors:
  - Elissar Mansour
  - Nawal Abi Raji
  - Pia Salloum
  - Nicolas Jreij
  - Thea Mila Ayoub
  - Mostafa Merheb
  - Philippe Attieh
  - Bernard Harbieh
  - Frederic Harb
  - Sami Azar
  - Hilda E Ghadieh
year: 2026
container: "Cardiology Research and Practice"
doi: 10.1155/crp/9734869
url: https://doi.org/10.1155/crp/9734869
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: null
notes: Discusses mechanisms and preventive strategies for cardiotoxicity induced by anthracyclines.

---
citation_id: cit-003
title: "Osimertinib-induced cardiotoxicity is driven by HDAC-dependent epigenetic repression and rescued by vorinostat"
authors:
  - Angelica Toro Cora
  - Arvind Singh Bhati
  - Allen Sam Titus
  - Ashish Jaiswal
  - Baldeep Singh
  - Prachi Umbarkar
  - Daniel Y Li
  - Roshan Dutta
  - Qinkun Zhang
  - Suresh K Verma
  - Sultan Tousif
  - Hind Lal
year: 2026
container: "Signal Transduction and Targeted Therapy"
doi: 10.1038/s41392-026-02814-1
url: https://doi.org/10.1038/s41392-026-02814-1
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: null
notes: Explores epigenetic mechanisms underlying osimertinib-induced cardiotoxicity.

---
citation_id: cit-004
title: "Beyond QSARs: Quantitative Knowledge-Activity Relationships (QKARs) for enhanced drug toxicity prediction"
authors:
  - Ting Li
  - Yanyan Qu
  - Alexander Chen
  - Shraddha Thakkar
  - Dongying Li
  - Weida Tong
year: 2025
container: "Toxicological Sciences"
doi: 10.1093/toxsci/kfaf135
url: https://doi.org/10.1093/toxsci/kfaf135
access_status: open_access
allowed_source: true
retrieved_on: 2026-08-25
pages_or_sections: null
notes: Discusses the use of QKARs for predicting drug-induced cardiotoxicity.
```